Pituitary Complications of Checkpoint Inhibitor Use.
Endocrinology
; 165(9)2024 Jul 26.
Article
in En
| MEDLINE
| ID: mdl-39001874
ABSTRACT
Immune checkpoint inhibitors have revolutionized cancer therapy but are associated with a risk of endocrine immune-related adverse events, including pituitary complications. Autoimmune hypophysitis, traditionally a rare diagnosis, has become a more frequently encountered clinical entity with the emergence of antitumor immunotherapy. This mini-review aims to consolidate current knowledge, encompassing the epidemiology, pathophysiology, clinical presentation, diagnosis, and management of pituitary complications of immune checkpoint inhibitor use.
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Immune Checkpoint Inhibitors
Limits:
Humans
Language:
En
Journal:
Endocrinology
Year:
2024
Document type:
Article
Affiliation country:
Estados Unidos